等待开盘 09-24 09:30:00 美东时间
+0.380
+1.38%
今日重点评级关注:瑞银:上调Gossamer Bio评级至"买入",目标价从1.25美元升至9美元;Canaccord Genuity:维持Corcept Therapeutics"买入"评级,目标价从137美元升至140美元
09-11 10:06
B of A Securities analyst Joanna Gajuk maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $27.5 to $31.
09-10 23:11
BrightSpring Health's (NYSE:BTSG) short percent of float has fallen 5.72% since...
08-14 00:00
There’s a lot to be optimistic about in the NA sector as 2 analysts just weighe...
08-13 19:10
BrightSpring Health (NASDAQ:BTSG) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.18 by 24.29 percent. This is a 120 percent increase over earnings of $0.10 per share from
08-01 18:22
BrightSpring Health (NASDAQ:BTSG) raises FY2025 sales outlook from $12.00 billion-$12.50 billion to $12.20 billion-$12.60 billion vs $12.35 billion estimate.
08-01 18:03
Companies Reporting Before The Bell • Brookfield Business (NYSE:BBUC) is expect...
08-01 16:32
BrightSpring Health (NASDAQ:BTSG) is preparing to release its quarterly earning...
08-01 01:01
BrightSpring Health's (NYSE:BTSG) short percent of float has risen 7.18% since ...
07-22 00:00
BrightSpring Health Services announced it will release its second quarter 2025 financial results on August 1, 2025, followed by an earnings conference call at 8:30 a.m. ET. Participants can register for the call in advance, and a live or archived webcast will be available on the company's investor relations website. BrightSpring provides home- and community-based healthcare solutions for complex populations, serving over 450,000 clients daily acr...
07-08 20:05